scispace - formally typeset
J

Jean-Pierre Gerard

Researcher at University of Nice Sophia Antipolis

Publications -  236
Citations -  10415

Jean-Pierre Gerard is an academic researcher from University of Nice Sophia Antipolis. The author has contributed to research in topics: Radiation therapy & Brachytherapy. The author has an hindex of 41, co-authored 227 publications receiving 9307 citations. Previous affiliations of Jean-Pierre Gerard include Claude Bernard University Lyon 1.

Papers
More filters
Journal ArticleDOI

Preoperative Radiotherapy With or Without Concurrent Fluorouracil and Leucovorin in T3-4 Rectal Cancers: Results of FFCD 9203

TL;DR: Preoperative chemoradiotherapy despite a moderate increase in acute toxicity and no impact on overall survival significantly improves local control and is recommended for T3-4, N0-2, M0 adenocarcinoma of the middle and distal rectum.
Journal ArticleDOI

Influence of the Interval Between Preoperative Radiation Therapy and Surgery on Downstaging and on the Rate of Sphincter-Sparing Surgery for Rectal Cancer: The Lyon R90-01 Randomized Trial

TL;DR: A long interval between preoperative irradiation and surgery provides increased tumor downstaging with no detrimental effect on toxicity and early clinical results, and when sphincter preservation is questionable, a long interval may increase the chance of a successful spHincter-saving surgery.
Journal ArticleDOI

Role of a 10-Gy boost in the conservative treatment of early breast cancer: results of a randomized clinical trial in Lyon, France.

TL;DR: The role of a 10-Gy boost to the primary tumor in the conservative treatment of early infiltrating breast carcinoma treated by limited surgery and radiotherapy is defined.
Journal ArticleDOI

Long-term outcomes of clinical complete responders after neoadjuvant treatment for rectal cancer in the International Watch & Wait Database (IWWD): an international multicentre registry study

Maxime J M van der Valk, +71 more
- 23 Jun 2018 - 
TL;DR: This dataset has the largest series of patients with rectal cancer treated with a W&W approach, consisting of approximately 50% data from previous cohort series and 50% unpublished data.